PMID: 8607681Apr 1, 1996Paper

Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations

The Annals of Thoracic Surgery
C Primack Pifarre R

Abstract

Aprotinin significantly decreases postoperative blood loss, yet its exact mechanism of action remains unproven. To study the cytoprotective effect on platelets, we collected blood samples from patients during cardiopulmonary bypass (CPB) operations performed with or without aprotinin. Analysis included whole-blood flow cytometry. The highest percentages of activated platelets (positive for GMP-140 expression) were bound to leukocytes and erythrocytes in all CPB patients. Platelet-platelet activation did not reveal any marked differences between groups. However, in the platelet-cell bound region, increased ristocetin-stimulated platelet activation was observed from 30 minutes on CPB to 90 minutes after CPB with aprotinin (11.9% +/- 5.1% to 33.1% +/- 8.6%; p < 0.05), but not without aprotinin (17.5% +/- 0.1% to 17.9% +/- 2.3%). Platelet autoactivation increased more in the untreated group with time on CPB. This study demonstrates that in the presence of aprotinin, platelets remain unstimulated during CPB and the von Willebrand GPIb-mediated activatability of platelets is preserved, thus maintaining a viable platelet population. Most important, this study reveals that these mechanisms are more related to platelet-leukocyte than to...Continue Reading

Citations

Jan 16, 2002·The Annals of Thoracic Surgery·R C LandisK M Taylor
Feb 4, 1999·The Annals of Thoracic Surgery·A Weerasinghe, K M Taylor
Sep 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Masashi TanakaTakashi Ino
Feb 20, 2003·Thrombosis Research·Marcus E CarrPhilip E Greilich
Jun 20, 1998·British Journal of Haematology·S Bannan, P G Martin
Aug 20, 2003·Journal of Neurosurgery·Celia C D'ErricoKarin M Muraszko
Sep 1, 1999·Journal of Cardiothoracic and Vascular Anesthesia·L Shore-Lesserson
Jan 6, 2000·Journal of Cardiothoracic and Vascular Anesthesia·C C D'ErricoE L Bove
Aug 5, 2000·The Journal of Thoracic and Cardiovascular Surgery·M PoullisR C Landis
Nov 28, 2001·The Annals of Thoracic Surgery·R C LandisK M Taylor
Mar 16, 2001·Expert Opinion on Pharmacotherapy·P P PunjabiK M Taylor
May 17, 2001·Scandinavian Cardiovascular Journal : SCJ·M WeiM Tarkka
Feb 11, 1999·Anesthesia and Analgesia·F IchinoseS Morita
Mar 29, 2000·Anesthesia and Analgesia·S A Kozek-LangeneckerA K Cheung
Jan 29, 2002·Anesthesia and Analgesia·Gregory A NuttallMark H Ereth
Jan 7, 2000·Anesthesia and Analgesia·S A Kozek-LangeneckerA K Cheung
Jul 9, 2004·Orthopedics·Jerrold H Levy, Edward Sypniewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
C R WildevuurW van Oeveren
The Journal of Thoracic and Cardiovascular Surgery
N HayashidaS Aoyagi
© 2021 Meta ULC. All rights reserved